Tg(Rho*)STM2Rieke
Transgene Detail
|
|
| Symbol: |
Tg(Rho*)STM2Rieke |
| Name: |
transgene insertion STM2, Fred Rieke |
| MGI ID: |
MGI:5640779 |
| Synonyms: |
Tg(RhoS334A/S338A/S343A) |
| Transgene: |
Tg(Rho*)STM2Rieke Location: unknown
|
| Alliance: |
Tg(Rho*)STM2Rieke page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutations: |
|
Insertion, Nucleotide substitutions
|
| |
|
Tg(Rho*)STM2Rieke expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Note |
| mouse |
Sag (MGI:98227) |
|
|
| |
|
Mutation details: The transgene expresses mouse Rho in which phosphorylating serines 334, 338 and 343 have been converted to inactivating alanines. Threonine-associated phosphorylation sites (T336, T340 and T342) remain functional. An A337V mutation was introduced to confer a linear epitope for mAb3A6, that allows specific recognition of transgenic versus endogenous opsin.
(J:221472)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:221472 Azevedo AW, et al., C-terminal threonines and serines play distinct roles in the desensitization of rhodopsin, a G protein-coupled receptor. Elife. 2015;4 |
| All: |
1 reference(s) |
|
Analysis Tools
